In a challenging market environment, Immunic, Inc. (NASDAQ:IMUX) stock has recorded a new 52-week low, dipping to $0.92. The biopharmaceutical company, which focuses on developing treatments for ...
AM(IST)on Tuesday in a weak market. Abbott India Ltd.(up 0.47 per cent) and Glenmark Pharmaceuticals Ltd.(up 0.44 per cent) ...
Motilal Oswal Mutual Fund A/C Motilal Oswal Large and Midcap Fund acquired 10.55 lakh shares (0.92 percent) at the same price. The following trades took place via bulk deals on January 31. CPT ...